https://doi.org/10.4081/reumatismo.2020.1325
Top 100 cited articles on ankylosing spondylitis
Submitted: 27 July 2020
Accepted: 10 October 2020
Published: 18 January 2021
Accepted: 10 October 2020
Abstract Views: 1667
PDF: 909
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Ankylosing spondylitis is a global health problem. There are continuous innovations in terms of etiopathogenesis, diagnosis, and treatment. Here, the top 100 most cited articles on ankylosing spondylitis during the last three decades are analyzed. On April 6, 2020, the Web of Science was screened from 1984 to 2020 using the terms ankylosing spondylitis; the top 100 most cited articles were identified. For bibliometric analysis, the name of the article, year of publication, author information, number of citations, name of the publishing journal, H-index, impact factor, countries of the authors, types of articles, and funding sources were recorded. The Altmetric attention was recorded using a program that automatically calculates the score. The total number of citations of the articles in the list ranged from 176 to 3700. Arthritis and Rheumatism (n=31) and Annals of the Rheumatic Diseases (n=27) were the two leading journals in which the majority of the articles were published. Germany produced most of the articles; Braun J was the most cited author. Randomized controlled clinical trials were found to constitute most of the articles (n=35). According to the citation number, studies evaluating classification criteria and disease activity indices and, according to the Altmetric Attention Score, studies addressing the prevalence and biological agents were prominent. We present a perspective on the extent to which the most cited articles on ankylosing spondylitis draw interest in the scientific community and on social media platforms.
Zhao X, Chen J, Pan Y, Feng H, Meng B, Meng Y (2019) A bibliometric analysis of the global research in ankylosing spondyloarthritis (2008–2017). Rheumatol Int 39(6):1091-1097.
DOI: https://doi.org/10.1007/s00296-019-04308-6
Ostergaard M, Lambert RG. Imaging in ankylosing spondylitis (2012). Ther Adv Musculoskelet Dis. 4(4):301-311.
DOI: https://doi.org/10.1177/1759720X11436240
Hermann KG, Althoff CE, Schneider U, Zühlsdorf S, Lembcke A, Hamm B, et al. (2005). Spinal changes in patients with spondyloarthritis: comparison of MR imaging and radiographic appearances. Radiographics 25(3):559-69.
DOI: https://doi.org/10.1148/rg.253045117
Borchert K, Meise D, König C, Braun S (2018). Ankylosing spondylitis causes high burden to patients and the healthcare system: results from a German claims database analysis. Rheumatol Int 38(11):2121–2131.
DOI: https://doi.org/10.1007/s00296-018-4124-z
Bornmann L, Marx W, Gasparyan AY, Kitas GD (2012). Diversity, value and limitations of the journal impact factor and alternative metrics. Rheumatol Int 32(7):1861-1867.
DOI: https://doi.org/10.1007/s00296-011-2276-1
Zimba O, Radchenko O, Strilchuk L (2020). Social media for research, education and practice in rheumatology. Rheumatol Int. 40(2):183-190.
DOI: https://doi.org/10.1007/s00296-019-04493-4
Yin X, Cheng F, Wang X, Mu J, Ma C, Zhai C et al. (2019) Top 100 cited articles on rheumatoid arthritis: a bibliometric analysis. Medicine 98(8).
DOI: https://doi.org/10.1097/MD.0000000000014523
Celik E, Dokur M, Uysal BB, Samanci NS, Demirelli FH (2020) Comparison of attention for cancer research on social media versus academia: An altmetric score analysis. Int J Hematol Oncol 30(1):032-042.
Andresen EM (2000) Criteria for assessing the tools of disability outcomes research. Arch Phys Med Rehabil 81 (12 Suppl 2):S15-20.
DOI: https://doi.org/10.1053/apmr.2000.20619
Mansoori P (2018) 50 years of Iranian clinical, biomedical, and public health research: a bibliometric analysis of the Web of Science Core Collection (1965–2014). J Glob Health https://doi.org/8(2):02070110.7189/jogh.08.020701
DOI: https://doi.org/10.7189/jogh.08.020701
Trueger NS, Thoma B, Hsu CH, Sullivan L, Peters L, Lin M (2015) The altmetric score: a new measure for article-level dissemination and impact. Ann Emerg Med 66:549-553.
DOI: https://doi.org/10.1016/j.annemergmed.2015.04.022
Huang W, Wang P, Wu Q (2018) A correlation comparison between Altmetric Attention Scores and citations for six PLOS journals. PLoS One 13(4).
DOI: https://doi.org/10.1371/journal.pone.0194962
Linden SVD, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum 27(4):361-368.
DOI: https://doi.org/10.1002/art.1780270401
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286-2291.
Calin A, Garrett S, Whitelock H, Kennedy LG, O’hea J, Mallorie P et al. (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281-2285.
Rudwaleit M, Van Der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J et al. (2009). The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777-783.
DOI: https://doi.org/10.1136/ard.2009.108233
Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ (2014) Global prevalence of ankylosing spondylitis. Rheumatology 53(4):650-657.
DOI: https://doi.org/10.1093/rheumatology/ket387
Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P et al. (2015) Secukinumab, an interleukin-17A inhibitor, ankylosing spondylitis. N Engl J Med 373(26):2534-2548.
DOI: https://doi.org/10.1056/NEJMoa1505066
Park W, Hrycaj P, Jeka S, Kovalenko V, Lysenko G, Miranda P et al. (2013) A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study. Ann Rheum Dis 72(10):1605-1612.
DOI: https://doi.org/10.1136/annrheumdis-2012-203091
Dougados M, Béhier JM, Jolchine I, Calin A, van der Heijde D, Olivieri I et al. (2001) Efficacy of celecoxib, a cyclooxygenase 2—specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum 44(1):180-185.
DOI: https://doi.org/10.1002/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K
Wanders A, Heijde DVD, Landewé R, Béhier JM, Calin A, Olivieri I et al. (2005) Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized The trial. Arthritis Rheum 52(6).
DOI: https://doi.org/10.1002/art.21054
Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW et al. (1996) Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39(12):2004-2012.
DOI: https://doi.org/10.1002/art.1780391209
Braun J, Baraliakos X, Listing J, Sieper J (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52(8).
DOI: https://doi.org/10.1002/art.21197
Burmester GR, Panaccione R, Gordon KB, McIlraith, MJ, Lacerda AP (2013) Adalimumab: term safety in 23 458 patients from global patient trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn’s disease. Ann Rheum Dis 72(4):517-524.
DOI: https://doi.org/10.1136/annrheumdis-2011-201244
Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J (2009) Assessment of SpondyloArthritis international Society. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68(1):18-24.
DOI: https://doi.org/10.1136/ard.2008.094870
Rudwaleit M, Listing J, Brandt J, Braun J, Sieper J (2004) Prediction of a major clinic response (BASDAI 50) to tumour necrosis factor α blockers in ankylosing spondylitis. Ann Rheum Dis 63(6):665-670.
DOI: https://doi.org/10.1136/ard.2003.016386
Bennett AN, McGonagle D, O’Connor P, Hensor EMA, Sivera F, Coates LC et al. (2008) Severity of baseline magnetic resonance imaging—evident sacroiliitis and HLA—B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 58(11):3413-3418.
Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J (2003). Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61-66.
DOI: https://doi.org/10.1007/s00296-002-0237-4
Reveille JD, Sims AM, Danoy P, Evans DM, Leo P, Pointon JJ et al. (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42(2):123.
DOI: https://doi.org/10.1038/ng.513
Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A et al. (2001) Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 68(4):918-926.
DOI: https://doi.org/10.1086/319509
Reveille JD, Ball EJ, Khan MA (2001) HLA–B27 and genetic predisposing factors in
DOI: https://doi.org/10.1097/00002281-200107000-00004
spondyloarthropathies. Curr Opin Rheumatol 13;265 -272.
Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH. (1994). Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 21: 3026
Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J et al. (2003). Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 48(4):1126-1136.
DOI: https://doi.org/10.1002/art.10883
Yurdakul OV, Rezvani A (2018) Can ultrasound be an assessment tool for sagittal spine mobility and chest expansion in patients with ankylosing spondylitis?. Medicine 97(39).
DOI: https://doi.org/10.1097/MD.0000000000012609
Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Østergaard M, Lambert RG (2009) Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 60(1):93-102.
DOI: https://doi.org/10.1002/art.24132
Bennett AN, McGonagle D, O’Connor P, Hensor EMA, Sivera F, Coates LC et al. (2008) Severity of baseline magnetic resonance imaging—evident sacroiliitis and HLA—B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 58(11):3413-3418.
DOI: https://doi.org/10.1002/art.24024
How to Cite
Bagcier, F., Yurdakul, O., & Ozduran, E. (2021). Top 100 cited articles on ankylosing spondylitis. Reumatismo, 72(4), 218–227. https://doi.org/10.4081/reumatismo.2020.1325
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- L. Ventura, Portrait of the artist as a sick man. Rheumatological pathography of James Joyce (1882-1941) , Reumatismo: Vol. 60 No. 2 (2008)
- F. Schiavon, M. Favero, V. Carraro, L. Riato, Septic arthritis: what is the role for the rheumatologist? , Reumatismo: Vol. 60 No. 1 (2008)
- C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco, Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies , Reumatismo: Vol. 75 No. 4 (2023)
- N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey, Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients , Reumatismo: Vol. 72 No. 2 (2020)
- S. Pirri, R. Talarico, D. Marinello, G. Turchetti, M. Mosca, A systematic literature review of existing tools used to assess medication adherence in connective tissue diseases: the state of the art for the future development of co-designed measurement tools , Reumatismo: Vol. 73 No. 3 (2021)
- I. Acosta-Colman, Z. Morel, A. Ayala Lugo, V. Jolly, I. de Guillén, P. Langjahr, M. Vazquez, M.T Martínez de Filártiga, M.E. Acosta, Clinical features and genetic biomarkers associated with different phenotypes of systemic lupus erythematosus in Paraguayan patients , Reumatismo: Vol. 75 No. 2 (2023)
- G. Adami, L. Idolazzi, C. Benini, E. Fracassi, A. Carletto, O. Viapiana, D. Gatti, M. Rossini, A. Fassio, Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement , Reumatismo: Vol. 75 No. 1 (2023)
- M.B. Ates, S. Karup, S. Ugurlu, Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency , Reumatismo: Vol. 75 No. 4 (2023)
- N. Ughi, R. Padoan, C. Crotti, S. Sciascia, G. Carrara, A. Zanetti, D. Rozza, S. Monti, D. Camellino, F. Muratore, G. Emmi, L. Quartuccio, S. Morbelli, K. El Aoufy, S. Tonolo, R. Caporali, S. De Vita, C. Salvarani, M.A. Cimmino, The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis , Reumatismo: Vol. 73 No. 4 (2021)
- F. Carubbi, A. Alunno, R. Gerli, R. Giacomelli, Histopathology of salivary glands , Reumatismo: Vol. 70 No. 3 (2018): Monographic issue on Histopathology in Rheumatic Diseases
<< < 24 25 26 27 28 29 30 31 32 33 > >>
You may also start an advanced similarity search for this article.
